Immunome IMNM Business Segments — Other Segment Expenses

Similar metrics at other companies

BOOTSingle Reportable — Other Segment Expenses

$12.78M+5.2%

ARQTReportable Segment — Other segment expenses

$5.86M-18.4%

SYNAReportable Segment — Other segment expenses (3)

$800K-95.4%

GRALReportable Segment — Other segment expenses

$9.43M-50.6%

ALHCReportable Segment — Other segment expenses

$21.91M-11.8%

RDDTReportable Segment — Other segment expenses

$1.07M+991%

Questions, answered.

What is Immunome's business segments — other segment expenses?

Immunome (IMNM) reported business segments — other segment expenses of -$8.56M in Q1 2026.

How has Immunome's business segments — other segment expenses changed year-over-year?

Immunome's business segments — other segment expenses decreased by 35.5% year-over-year, from -$6.31M to -$8.56M.

What does business segments — other segment expenses mean?

Encompasses miscellaneous operating expenses attributable to the business segment that do not fit into standard R&D or G&A categories. This may include one-time restructuring costs, legal settlements, or other non-recurring operational charges. It is used to capture the full scope of segment-specific spending that impacts the bottom line.